跳至主要内容
临床试验/NL-OMON44085
NL-OMON44085已完成不适用

ALLOGENEIC VERSUS AUTOLOGOUS SERUM EYE DROPS: A DOUBLE-BLIND RANDOMIZED CROSS OVER TRIAL - Allogeneic versus autologous serum eye drops

Sanquin Bloedbank0 个研究点目标入组 18 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - chronic dry eye syndrome
  • - age 18 or higher
  • - expected to benefit from SEDs
  • - can donate sufficient blood to prepare autologous SEDs
  • - meet the donor guidelines of Sanquin (except for age, donation frequency and hemoglobin concentration)

排除标准

  • - has corneal lesions more than punctates
  • - has a history of unstable Herpes simplex virus (HSV) keratitis or is treated for HSV keratitis
  • - currently already uses SEDs
  • - pregnancy, lactating, or intending the become pregnant in the next 3 months
  • - unable or unwilling to give informed consent
  • - active (systemic) microbial infection
  • - poor venous access

研究者

发起方
Sanquin Bloedbank

相似试验